Safety, pharmacokinetics and activity of CA-4948, an IRAK4 inhibitor, for treatment of patients with relapsed or refractory hematologic malignancies: Results from the phase 1 study Meeting Abstract
| Authors: | Nowakowski, G. S.; Leslie, L. A.; Younes, A.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Landsburg, D. J.; Martinez, E.; von Roemeling, R.; Lieberman, C.; Tun, H. W. |
| Abstract Title: | Safety, pharmacokinetics and activity of CA-4948, an IRAK4 inhibitor, for treatment of patients with relapsed or refractory hematologic malignancies: Results from the phase 1 study |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205605123 |
| DOI: | 10.1182/blood-2020-140857 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 44 -- Source: Wos |
